Skip to main content

Free Content Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253

Download Article:
 Download
(PDF 343.3427734375 kb)
 
BACKGROUND: Improved tuberculosis (TB) screening is urgently needed for human immunodeficiency virus (HIV) infected patients.

METHODS: An observational, multi-country, cross-sectional study of HIV-infected patients to compare a standardized diagnostic evaluation (SDE) for TB with standard of care (SOC). SOC evaluations included TB symptom review (current cough, fever, night sweats and/or weight loss), sputum Ziehl-Neelsen staining and chest radiography. SDE screening added extended clinical signs and symptoms and fluorescent microscopy (FM). All participants underwent all evaluations. Mycobacterium tuberculosis on sputum culture was the primary outcome.

RESULTS: A total of 801 participants were enrolled from Botswana, Malawi, South Africa, Zimbabwe, India, Peru and Brazil. The median age was 33 years; 37% were male, and median CD4 count was 275 cells/mm3. Thirty-one participants (4%) had a positive culture on Löwenstein-Jensen media and 54 (8%) on MGIT. All but one positive culture came from sub-Saharan Africa, where the prevalence of TB was 54/445 (12%). SOC screening had 54% sensitivity (95%CI 40–67) and 76% specificity (95%CI 72–80). Positive and negative predictive values were respectively 24% and 92%. No elements of the SDE improved the predictive values of SOC.

CONCLUSIONS: Symptom-based screening with smear microscopy was insufficiently sensitive. More sensitive diagnostic testing is required for HIV-infected patients.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: HIV infection; diagnostics; sensitivity; specificity; tuberculosis

Document Type: Research Article

Affiliations: 1: University of Nebraska Medical Center, Omaha, Nebraska, USA 2: Harvard School of Public Health, Boston, Massachusetts, USA 3: National AIDS Research Institute, Pune, India 4: Centers for Disease Control and Prevention, Atlanta, Georgia, USA 5: University of Pennsylvania, Philadelphia, Pennsylvania, USA 6: Albert Einstein College of Medicine, Bronx, New York, USA 7: Johns Hopkins University, Baltimore, Maryland, USA 8: Instituto de Pesquisa Clinica Evandro, Rio de Janeiro, Rio de Janeiro, Brazil 9: Scottish Livingstone Hospital, Molepole, Botswana 10: Princess Marina Hospital, Gaborone, Botswana 11: Center for the AIDS Programme of Research in South Africa, Durban, South Africa 12: University of KwaZulu-Natal, Durban, South Africa 13: AIDS Clinical Trials Group Operations Center, Silver Spring, Maryland, USA 14: University of California San Francisco, San Francisco, California, USA 15: Montgomery County Health Department, Silver Spring, Maryland, USA 16: Stanford University Medical Center, Stanford, California, USA

Publication date: 2013-04-01

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more